Thermo Fisher Scientific Stock News

Bio-Techne (TECH) signed an agreement with Thermo Fisher Scientific (TMO) to exclusively complete the development and commercialize ExoTRU kidney transplant rejection test developed

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Epigenetics Market finds that increasing cancer rates may further expediting market growth. Primarily driven by increasing research activity and funding for Epigenetics, the total Global Epigenetics Market is estimated to reach USD 3.0 Billion by 2028. The market stood at a revenue of USD 0.8 Billion in the year 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.1%. Furthermore, the increasing personalized medication, and target therapy are also anticipated to augment the growth of the Global Epigenetics Market, states Vantage Market Research, in a report, titled " Epigenetics Market by Product (Instruments, Reagents & Kits, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Gene Synthesis Market finds that rising prevalence of infectious diseases as well as chronic diseases is expediting market growth. Primarily driven by high efficiency, the total Global Gene Synthesis Market is estimated to reach USD 6.58 Billion by 2028, up from USD 2.16 Billion in 2021, at a compound annual growth rate (CAGR) of 17.9%. Furthermore, supportive government policies associated with synthetic biology and surging investments from government as well as major players to augment the growth of the Global Gene Synthesis Market, states Vantage Market Research, in a report, titled " Gene Synthesis Market by End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations), by Method (Oligonucleotide Synthesis, Gene Assembly), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Riding The Stock Waves: Update On The Medical Devices Sector

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the global 3D Cell Culture Market finds that increasing incidence of chronic diseases is expediting market growth. Primarily driven by increasing focus on developing alternatives to animal testing, the total global 3D Cell Culture Market is estimated to reach USD 2,051.5 Million by 2028 . The Market stood at a revenue of USD 905.8 Million in the year 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 15.1%. Furthermore, the growing focus on personalized medicine is also anticipated to augment the growth of the global 3D Cell Culture Market, states Vantage Market Research, in a report, titled " 3D Cell Culture Market by Technology (Scaffold based, Scaffold free, 3D Bioreactors), by Application (Cancer, Tissue engineering & Immunohistochemistry, Drug development, Stem cell research), by End Use (Biotechnology and pharmaceutical industries, Research laboratories and institutes, Hospitals and diagnostic centers, Others), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Pune, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market report delivers a complete overview of key components like drivers, limitations, historic and current trends, technical development, and future growth. Research report contains company analysis, size, share, revenue and sales of the company, current advancements. Digital PCR and Real-Time PCR market analysis also focuses on the global key top industry players in the market, with details such as company profiles, capacity, production, price, cost, revenue. Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/20190575 The global Digital PCR and Real-Time PCR market size is projected to reach USD 1879.8 million by 2028, from USD 1180.1 million in 2021, at a CAGR of 6.8% during 2022-2028.  Polymerase chain reaction (PCR) is a laboratory technique performed commonly to amplify DNA, thereby producing many copies of a particular section of DNA in interest.

Thermo Fisher Scientific (TMO) will invest $40M to expand its single-use technology manufacturing facility in Millersburg, Pennsylvania.The company said the the expansion is part of a…

Investors are optimistic about Thermo Fisher's (TMO) better-than-expected fourth-quarter results and impressive COVID-19 response-related revenues.

Las Vegas, USA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Molecular Diagnostics Market is Expected to Grow at a Substantial CAGR of 9.21% and is Contemplated to Reach USD 16.12 Billion by 2026, Estimates DelveInsight Molecular Diagnostics Market is contemplated to witness huge demand in the upcoming years due to rising infectious diseases and their diagnosis, the presence of global as well as regional manufacturers active in developing the Molecular Diagnostic products such as Qiagen, Roche, Molbio Diagnostics Pvt. Ltd., among others. Also, improving healthcare infrastructure, government initiatives in raising awareness regarding molecular diagnosis will contribute to the Molecular Diagnostics market growth in these regions. DelveInsight''s Molecular Diagnostics Market Insights and Forecast report provides the current and forecast Molecular Diagnostics Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Molecular Diagnostics Market.

Thermo Fisher Scientific Inc found using ticker (TMO) now have 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 745 and 605 calculating the average target price we see 691.71. Now with the previous closing price of 580.28 this now indicates there is a potential upside of 19.2%. The 50 day moving average now sits at 616.56 and the 200 moving average now moves to 562.3. The market capitalisation for the company is $223,145m. Visit the company website at: https://www.thermofisher.com [stock_market_widget type="chart" symbol="TMO" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $265,996m based on the market concensus. Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company''s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Major players in the pyrogen testing market are Thermo Fisher Scientific Inc. , Merck KGaA, Charles River Laboratories Inc. , Lonza Group, Ellab A/S, Nelson Laboratories Inc. , Associates of Cape Cod Inc. Major players in the pyrogen testing market are Thermo Fisher Scientific Inc. , Merck KGaA, Charles River Laboratories Inc. , Lonza Group, Ellab A/S, Nelson Laboratories Inc. , Associates of Cape Cod Inc.

WASHINGTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Pharmaceutical Membrane Filtration Market finds that growth in the production of biopharmaceuticals is expediting market growth. Primarily driven by advancements in nanofiltration technologies, the total global Pharmaceutical Membrane Filtration Market is estimated to reach USD 14.16 Billion by 2028, up from USD 6.48 Billion in 2021, at a Compound Annual Growth Rate (CAGR) of 11.8%. Furthermore, the surging adoption of single-use technologies is also anticipated to augment the growth of the global Pharmaceutical Membrane Filtration Market, states Vantage Market Research, in a report, titled: " Pharmaceutical Membrane Filtration Market by Product (Filters, Systems, Accessories), by Technique (Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis), by Material (PES, PVDF, Nylon, PTFE), by Application (Final Product Processing, API Filtration, Sterile Filtration, Protein Purification), by Region (North America, Europe, Asia Pacific, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Is there still money to be made in Thermo Fisher Scientific Inc. ( TMO , Financial) stock? Analysts think so.